
ABL, Inc.
Rockville, MD, United States ablinc.com From their website, Nov 2026
- GMP
- ISO 9001
Work here? Claim this listing
About
ABL, Inc. provides contract manufacturing and laboratory research services for vaccines and therapies, with headquarters in Rockville, Maryland and additional biomanufacturing locations in Europe. The company supports clients from process development through GMP manufacturing, QC testing, and banking for viral and gene therapy programs.
Services
Biomanufacturing
Provides GMP biomanufacturing services for viral products and related therapeutics, including development, production, and testing.
CDMO: development & manufacturing
Virus Manufacturing
Manufactures viral vectors and viral products across suspension and adherent platforms for gene therapy, vaccines, oncolytics, and immunotherapies.
CDMO: development & manufacturing
Process Development
Conducts upstream and downstream process development and optimization for cGMP-compliant manufacturing processes.
Aseptic Fill Finish
Performs GMP aseptic fill/finish for drug substance and drug product.
CDMO: development & manufacturing
Cell & Virus Banking
Provides GMP cell and virus banking for development and manufacturing programs.
Biologics and QC Testing
Provides analytical and QC testing services for viral vector and protein products, including release and stability testing.
Government Partnering
Provides partnering support for government-related programs.
ELISA Kits
Sells ELISA kits, including HIV-1 p24 and SIV p27 assays.
5 more services
- Immunoassay development
- Immunogenicity studies
- Biomarker analyses
- Pharmacokinetic/pharmacodynamic studies
- QA/Regulatory support
- Minimums and prices
- 5421 – HIV-1 p24 Antigen Capture Assay: $654.50
- 5447 – Bulk HIV-1 p24 10 plates/kit: $5,824.50
- 5436 – SIV p27 Antigen Capture Assay: $765.75
- 5450 – Bulk SIV p27 10 plates/kit: $6,549.25
Capabilities
- Assays and studies
- Process development
- Fill-finish
- ELISA
- AAV
- Bioreactors
- Stability studies
22 more
- Lentivirus
- Analytical development
- PK/PD
- Immunoassays
- Immunogenicity studies
- Biomarker analyses
- Mechanism of action studies
- Correlates of protection studies
- Pharmacokinetic/pharmacodynamic studies
- Methods development
- Method transfer
- Method optimization
- Qualification
- Validation
- Sterility
- Mycoplasma
- Bioburden
- Endotoxin
- Custom assays
- Immunogenicity assays
- Analytical lot release testing
- Stability testing
- Scale and capacity
- Up to 400L
- 50L, 200L, 400L bioreactor seed trains
- Small lot fills (> 200 vials)
- 10 plates/kit
- Single-use Bioreactors (SUBs) up to 400L
- 50 x 36 layer HYPERStacks
3 more
- 40 x 10 layer Cell Factories or CellSTACKs
- 24 x 40 layer Cell Factories (40CFs)
- 6,500 m2 GMP manufacturing site in Lyon, France
- Therapeutic areas
- Vaccines
- Gene therapy
- Cell therapy
- Oncolytic virotherapies
- Immunotherapies
- Biotherapeutics
Instruments and platforms
- Waters HPLC/UPLC ACQUITY H-Class BIO QSM
- Waters 2695 HPLC
- Beckman Coulter Vi-CELL
- Sartorius Stedim Biostat STR
- iCELLis Bioreactor
- HyperStacks
4 more
- Cell Factories
- CellSTACKs
- RollerCell 40 System
- Traditional roller bottles
Modalities and species
- Modalities
- Viral vector
- Cell therapy
- Recombinant protein
- Vaccine
- Species and models
- Human clinical trials
- Preclinical animal studies
- Cell line
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing and testing
ISO 9001Self-reported
Scope: manufacture of drug substance and aseptically prepared small volume liquid (drug product) viral products
Details
- Type
- CRDMO
- Founded
- 1991
- Address
- 9800 Medical Center Drive, Building D Rockville, MD 20850 USA
- Sites
- Strasbourg, France
- Lyon, France
- Serves
- Worldwide, global, U.S., Europe